KojoX is FUJIFILM Diosynth Biotechnologies' global operating framework focused on the flexibility and scalability of biologics manufacturing.[1] The system works on the principle of modular cloning of equipment, where the design, equipment, software and operating model are standardized and can be replicated at different locations.[1] This modular approach enables faster construction of new facilities and reduces the cost of their construction.[1] KojoX covers the entire production chain from the production of the active ingredient to the production of medicines to the final packaging.[1] Harmonized equipment design allows validated processes to be transferred to new, equivalent production lines within the global network without the need for additional technical transfers.[2] According to the company, KojoX should reduce technical transfer times to production by approximately 40 percent.[5] This approach gives pharmaceutical companies access to modular, scalable manufacturing capacity in various locations including the US, UK, Denmark and Japan.[2]